Form D — Indapta Therapeutics Inc.
0001910175-25-000003 · filed 2025-10-14
Offering
- Industry
- Other Technology
- Exemptions
- 06b
- Total offering
- $51,574,072
- Total sold
- $50,800,176
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Indapta Therapeutics Inc.
- CIK
- 1910175
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 5000 Gulf Fwy. Building 4
Houston, TX 77023 - Phone
- 917-282-9768
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Mark Frohlich · Executive OfficerHouston, TX Find on LinkedIn ↗
-
Ronald Martell · DirectorHouston, TX Find on LinkedIn ↗
-
Lori Hu · DirectorHouston, TX Find on LinkedIn ↗
-
Fabio Pucci · DirectorHouston, TX Find on LinkedIn ↗
View original on SEC EDGAR.